obesity-2016_keynote

7 / 11

Volume 6, Issue 9(Suppl) J Obes Weight Loss Ther 2016
ISSN: 2165-7904 JOWT, an open access journal Obesity 2016
December 08-10, 2016
Page 31
Notes:
conferenceseries.com
Obesity & Weight Management
December 08-10, 2016 Dallas, USA
10th International Conference and Exhibition on
Nontypical points of obesity
During past few years the prevalence of obesity has increased dramatically. Obesity traditionally has been defined as a
disease characterized by body fat accumulation to an extent that causes health disturbances, such as insulin resistance,
type 2 diabetes mellitus, hypertension, dyslipidemia, cardiovascular disease, stroke, sleep apnea, gallbladder disease and some
types of cancer. On the other side, obesity isn’t homogeneous disease- cardiometabolic disturbances, which are associated
with obesity, do not, however, affect all obese people. Several studies suggest that "Metabolically healthy but obese" - MHO
people show specific phenotype and body composition differences compared with obese patients “at risk”. MHO individuals
exhibit lower total and intra-abdominal fat mass, lower ectopic fat accumulation and favorable metabolic, hormonal, immune
and inflammatory profile. It is not clear what induces potential transition from metabolically healthy to unhealthy profile,
and whether genetic, environmental, lifestyle and psychosocial factors have role. Metabolically obese but normal weight –
MONW individuals present a subgroup of individuals with normal BMI, and with insulin resistance, higher risk of developing
type 2 diabetes, cardiovascular disease, atherosclerosis and mortality. The early identification of individuals with the MONW
phenotype would be beneficial and may have important therapeutic implications. Clinical guidelines should be target more to
MHO population, especially to standardization of definition criteria. Future studies should elucidate mechanisms of preserved
favorable metabolic profile, and specific dynamics of metabolic and neuroendocrine processes in MHO individuals, which
may be helpful in tailoring potential interventions.
Biography
Edita Stokić, MD, PhD, is an Endocrinologist, Professor of Internal Medicine-Endocrinology, employed in the Clinic of Endocrinology, Diabetes and Metabolic
Disorders of the Clinical Centre of Vojvodina in Novi Sad, Medical Faculty, Serbia. In 2005, she was appointed as Chief of Department. She is currently the Vice
President of Serbian Association for the Study of Obesity and Chairman of the Continuing Education Board (Society of Physicians of Vojvodina of the Medical
Society of Serbia). She was President of the Internal Medicine Section and President of Endocrinology Section within same Society. She is an author or co-author
of 412 scientific articles, and has publications on obesity, dyslipidemias and diabetes. She has also published monographs namely Obesity is a Treatable Disease,
and Obesity and Adipose Tissue Distribution – Metabolic Consequences.
Edita Stokić
Clinical Centre of Vojvodina, Serbia
Edita Stokić, J Obes Weight Loss Ther 2016, 6:9(Suppl)